12 October 2020

Highlights in Medicinal Chemistry IV

This event runs back to back with Automated Intelligent Chemistry

Organised by:

SCI's Fine Chemicals Group

London, UK

Register your interest

Registration Closed

This event is no longer available for registration.


This meeting aims to showcase vignettes of modern medicinal chemistry to bring new thinking to the subject, challenge perceptions and encourage scientific interaction between researchers. The short presentation format of the meeting also aims to provide a focussed forum to promote examples of medicinal chemistry excellence.


This meeting is targeted at academic and industrial scientists engaged in all aspects of the drug discovery process and those interested in broadening their knowledge at the forefront of medicinal chemistry.


SCI Members attending this meeting are able to claim CPD points.


This event runs back to back with Automated Intelligent Chemistry


The full programme will be announced in due course.

Confirmed Speakers
  • Dr Mark Bunnage, Vertex (Plenary speaker)
  • Dr Bayard Huck, Merck DE
  • Dr Will Farnaby, University of Dundee

Call for Abstracts

Abstracts for short talks with contributions from the whole field of medicinal chemistry are now invited: Please submit a one-page abstract to conferences@soci.org by Friday 15 May 2020.

Venue and Contact


14/15 Belgrave Square

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Delegate fees and booking details will be announced in due course.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions



Exhibition and Sponsorship

An exhibition will take place alongside the conference during refreshment breaks for companies and related organisations who may wish to exhibit. For further information and prices, please email conferences@soci.org. Spaces are limited and will be allocated on a first come, first served basis.

Organising Committee
  • Jo Pinder, SCI/ Vertex Ltd, UK
  • Jamie Scott, SCI/ AstraZeneca
  • Al Dossetter, SCI/ MedChemica Limited
  • Nigel Swain, SCI/ Heptares Therapeutics